Clinical Trial Update: TRAQinform Assessment of Immunotherapy Response

View source ↗

Summary

A completed clinical trial evaluating TRAQinform, an assessment tool for immunotherapy response in melanoma. The study is sponsored by AIQ Solutions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: AIQ Solutions | Conditions: Melanoma | Status: COMPLETED